BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7481726)

  • 1. A new class of antihypertensive: angiotensin II receptor antagonists.
    McCoy R
    S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726
    [No Abstract]   [Full Text] [Related]  

  • 2. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible ageusia associated with losartan.
    Schlienger RG; Saxer M; Haefeli WE
    Lancet; 1996 Feb; 347(8999):471-2. PubMed ID: 8618505
    [No Abstract]   [Full Text] [Related]  

  • 4. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 5. Angioedema associated with angiotensin II receptor antagonist losartan.
    Sharma PK; Yium JJ
    South Med J; 1997 May; 90(5):552-3. PubMed ID: 9160080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin II receptor antagonists. Clinical relevance].
    Scholze J
    Internist (Berl); 1996 Jun; 37(6):636-42. PubMed ID: 8767999
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin II receptor antagonists].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710
    [No Abstract]   [Full Text] [Related]  

  • 8. Losartan and angina pectoris.
    Ahmad S
    Tex Heart Inst J; 1995; 22(4):347-8. PubMed ID: 8605440
    [No Abstract]   [Full Text] [Related]  

  • 9. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM; Goldberg AI
    Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 15. Losartan: first of a new class of angiotensin antagonists for the management of hypertension.
    Carr AA; Prisant LM
    J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II type 1 receptor blocker losartan in clinical practice: a review.
    Gavras HP; Salerno CM
    Clin Ther; 1996; 18(6):1058-67; discussion 1057. PubMed ID: 9001823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
    Triggle DJ
    Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
    J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor antagonists as a treatment for hypertension.
    MacFadyen RJ; Reid JL
    J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.